• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Stemline Therapeutics Inc

+ Add to Watchlist

STML:US

11.9500 USD 0.8600 6.71%

As of 20:10:00 ET on 08/01/2014.

Snapshot for Stemline Therapeutics Inc (STML)

Open: 12.8100 Day's Range: 11.7710 - 12.8100 Volume: 145,311
Previous Close: 12.8100 52wk Range: 10.6800 - 47.2500 1-Yr Rtn: -51.18%

Stock Chart for STML

No chart data available.
  • STML:US 11.9192
  • 1D
  • 1M
  • 1Y
12.8100
Interactive STML Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for STML

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.3000
Est. EPS (USD) (12/2014) -2.7640
Est. PEG Ratio -
Market Cap (M USD) 158.27
Shares Outstanding (M) 13.24
30 Day Average Volume 131,178
Price/Book (mrq) 2.2044
Price/Sale (ttm) 1,080.9010
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for STML

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for STML

Stemline Therapeutics Inc. provides biopharmaceutical services. The Company offers research, discovery, and development of novel compounds that target cancer stem cells.

Ivan BergsteinChairman/President/CEOKenneth HobermanCOO/Secretary
Eric Keith RowinskyExec VP/Chief Medical OfcrDavid G GioncoVP:Finance/Chief Acctg Officer
More Company Profile & Key Executives for STML

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil